Compare COHN & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COHN | MDAI |
|---|---|---|
| Founded | 1999 | 2013 |
| Country | United States | United States |
| Employees | N/A | 78 |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.7M | 39.6M |
| IPO Year | 2003 | N/A |
| Metric | COHN | MDAI |
|---|---|---|
| Price | $19.29 | $2.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 19.0K | ★ 851.1K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | ★ 5.07% | N/A |
| EPS Growth | ★ 5537.50 | N/A |
| EPS | ★ 4.35 | N/A |
| Revenue | ★ $275,564,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.53 | ★ N/A |
| Revenue Growth | ★ 246.19 | N/A |
| 52 Week Low | $6.41 | $1.13 |
| 52 Week High | $32.60 | $3.21 |
| Indicator | COHN | MDAI |
|---|---|---|
| Relative Strength Index (RSI) | 63.38 | 74.30 |
| Support Level | $17.09 | $2.02 |
| Resistance Level | $20.19 | $2.82 |
| Average True Range (ATR) | 1.14 | 0.14 |
| MACD | 0.48 | 0.05 |
| Stochastic Oscillator | 91.73 | 100.00 |
Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.